Impact of an Educational Personalized Clinical Support Device Preventive and a Referent Nurse in Surgery for Obesity — IRCO

Dumping Syndrome Clinical Trial

Official title:
Assessing the Impact of an Educational Personalized Clinical Support Device Preventive and a Referent Nurse in Surgery for Obesity With the Risk of Occurrence of Dumping Syndrome After Gastric Bypass.

Status Completed

Clinical Trial Summary

The postprandial dumping syndrome is a frequent consequence of Roux-en-Y Gastric ByPass due to the rapid emptying of the stomach remnant in to the intestinal lumen. Dumping-related symptoms occur very early after eating (within 30 minutes), are not associated with concurrent hypoglycemia, and are most prominent in the early postoperative period. This syndrome very debilitating for the patient can be improved by dietary and nutritional recommendations. We hypothesize that a personalized approach based on dietary and nutritional recommendations conducted by a nurse would likely to decrease the frequency of dumping syndrome and improve the postoperative quality of life of patients in the early postoperative period.

Clinical Trial Description

The Roux-en-Y Gastric ByPass is considered the gold standard of weight loss surgery and is the most commonly performed bariatric procedure worldwide.The postprandial dumping syndrome is a frequent consequence of gastrojejunal anastomosis due to the rapid emptying of the stomach remnant in to the intestinal lumen. Dumping-related symptoms occur very early after eating (within 30 minutes), are not associated with concurrent hypoglycemia, and are most prominent in the early postoperative period. The symptoms of dumping syndrome include nausea, abdominal cramps, diarrhea, dizzy spells, weakness and cold sweats either with or after eating.This syndrome very debilitating for the patient can be improved by dietary and nutritional recommendations. We hypothesize that an individualized approach based on dietary and nutritional recommendations and monitoring of patients conducted by a nurse in the first three months after surgery would likely to decrease these problems and improve the postoperative quality of life of patients. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02891330
Study type	Interventional
Source	University Hospital, Lille
Contact
Status	Completed
Phase	N/A
Start date	March 2, 2017
Completion date	December 18, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05759689` - Fat Supplementation on Dumping Syndrome Related Symptoms After Gastric Surgery	N/A
Recruiting	`NCT04028193` - Fat Supplementation on Dumping Syndrome Associated Symptoms	N/A
Recruiting	`NCT00543179` - Treatment of the Dumping Syndrome With Lanreotide Autogel®	Phase 4
Not yet recruiting	`NCT04522193` - Dumping Syndrome and Esophageal Atresia	N/A
Completed	`NCT02525705` - Dumping Syndrome After Operation of Esophageal Atresia Type III	N/A
Active, not recruiting	`NCT01794793` - Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies	Phase 4
Completed	`NCT03734627` - Gastrointestinal Nutrient Transit and Enteroendocrine Function After Upper Gastrointestinal Surgery
Terminated	`NCT02836353` - Metabolic Consequences of Gastrointestinal Surgery	N/A
Completed	`NCT05057819` - Investigating the Impact of the SGLT2 Inhibitor Empagliflozin on Postprandial Hypoglycaemia After Gastric Bypass	Phase 4
Completed	`NCT02971631` - Gastrectomy, Eating Behaviour and GLP-1	N/A
Completed	`NCT01923649` - SOMATULINE Autogel 90 mg IN DUMPING SYNDROME	Phase 2